Skip to main content

Table 2 Patient demographic and clinical characteristics at baseline according to gender (Phase 2)

From: Effectiveness of a drug dosing service provided by community pharmacists in polymedicated elderly patients with renal impairment — a comparative study

Mean ± SD Women (103) Men (71) Overall (174)
Age (years) 81. ± 7.5 80.5 ± 7.0 80.8 ± 7.3
Weight (kg) 61.9 ± 10.7 73.9 ± 10.1 66.8 ± 12.0
Height (m) 1.5 ± 0.1 1.7 ± 0.1 1.6 ± 0.1
BMI (Kg/m2) 26.0 ± 4.2 26.6 ± 3.1 26.3 ± 3.8
SBP (mm Hg) 136.3 ± 1932 132.4 ± 17.8 134.7 ± 18.7
DBP (mm Hg) 75.8 ± 12.0 73.9 ± 12.6 75.0 ± 12.6
Creatinine (mg/dl) 1.0 ± 0.3 1.5 ± 1.1 1.2 ± 0.8
Body surface (m2) 1.6 ± 0.2 1.8 ± 0.2 1.7 ± 0.2
GFR (ml/min/1.73 m2) 61.3 ± 14.5 59.8 ± 20.0 60.7 ± 17.0
CrCl (ml/min) 45.2 ± 11.2 46.9 ± 15.2 45.9 ± 12.3
CrCl-BS (ml/min/1.73 m2) 48.3 ± 11.5 45.2 ± 13.9 47.1 ± 12.6
Total number of drugs per patient 6.3 ± 3.3 6.2 ± 3.0 6.3 ± 3.1
Drugs wit restriction in RI per patient 3.5 ± 2.1 3.5 ± 2.0 3.5 ± 2.1
Number of DRP per patient 0.4 ± 0.9 0.6 ± 1.0 0.5 ± 0.9
Prevalence of DI (%) 18.9 ± 30.7 12.4 ± 24.2 15.5 ± 28.6
Population with DRP %(n) 35.0(36) 19.7(14) 28.7(50)
Comorbidity %(n)    
 Hypertension 709.%(73) 67.6%(48) 69.5%(121)
 T2Dm 13.6%(14) 8.5%(6) 11.5%(20)
 Dyslipidemia 42.%(44) 29.6%(21) 37.4%(65)
 Hyper/Hypo/Thy 9.7%(10) 1.4%(1) 6.3%(11)
 CVD 19.4%(20) 29.6%(21) 23.6%(41)
  1. Abbreviations: BMI Body Mass Index, SBP Systolic Blood Pressure, DBP Diastolic Blood Pressure; T2DM Type 2 Diabetes Mellitus, CVD Cardiovascular Disease, THY Thyroidism, GFR Rate of Glomerular filtration, CrCl Creatinine Clearance, CrCl-BS Creatinine Clearance adjusted to body surface, RI renal impairment, DRP Drug-related problem, DI Dosing inadequacy, Drugs with restrictions (dose adjustment needed in case of renal impairment (RI)) per patient [2022], SD Standard deviation.